Scalable and resilient SARS-CoV-2 testing in an Academic Centre
…, M Howell, M Hubank, D Hughes, R Instrell… - medRxiv, 2020 - medrxiv.org
The emergence of the novel coronavirus SARS-CoV-2 has led to a pandemic infecting more
than two million people worldwide in less than four months, posing a major threat to …
than two million people worldwide in less than four months, posing a major threat to …
Scalable and Resilient SARS-CoV2 testing in an Academic Centre (preprint)
…, M Howell, M Hubank, D Hughes, R Instrell… - 2020 - pesquisa.bvsalud.org
The emergence of the novel coronavirus SARS-CoV-2 has led to a pandemic infecting more
than two million people worldwide in less than four months, posing a major threat to …
than two million people worldwide in less than four months, posing a major threat to …
[HTML][HTML] Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
To evaluate these risks, we enrolled 200 patient-facing HCWs between March 26 and April 8,
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …
Additional information for" Scalable and Robust SARS-CoV-2 testing in an Academic Centre"
Crick Covid Consortium - 2020 - crick.figshare.com
… , Rachel Instrell, Deb Jackson, Mariam Jamal-Hanjani, Ming Jiang, Mark Johnson, Leigh
Jones, Nnennaya Kanu, George Kassiotis, Stuart Kirk, Svend Kjaer, Andrew Levett, Lisa Levett, …
Jones, Nnennaya Kanu, George Kassiotis, Stuart Kirk, Svend Kjaer, Andrew Levett, Lisa Levett, …
[HTML][HTML] Scalable and robust SARS-CoV-2 testing in an academic center
…, M Howell, M Hubank, D Hughes, R Instrell… - Nature …, 2020 - nature.com
To the Editor—The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
1–3 has led to a pandemic infecting more than seven million people worldwide in …
1–3 has led to a pandemic infecting more than seven million people worldwide in …
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy
In this cohort study, we aim to compare outcomes from coronavirus disease 2019 (COVID-19)
in people with severe epilepsy and other co-morbidities living in long-term care facilities …
in people with severe epilepsy and other co-morbidities living in long-term care facilities …
[HTML][HTML] SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay
…, M Howell, M Hubank, R Instrell… - Wellcome Open …, 2021 - ncbi.nlm.nih.gov
The ongoing pandemic of SARS-CoV-2 calls for rapid and cost-effective methods to accurately
identify infected individuals. The vast majority of patient samples is assessed for viral …
identify infected individuals. The vast majority of patient samples is assessed for viral …
Standard operating procedures for SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay
…, K Gulati, S Hindmarsh, M Howell, M Hubank, R Instrell… - medRxiv, 2020 - medrxiv.org
The ongoing pandemic of SARS-CoV-2 calls for rapid and cost-effective methods to accurately
identify infected individuals. The vast majority of patient samples is assessed for viral …
identify infected individuals. The vast majority of patient samples is assessed for viral …
[HTML][HTML] Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems
RJ Harding, P Loppnau, S Ackloo, A Lemak… - Journal of Biological …, 2019 - ASBMB
The gene mutated in individuals with Huntington's disease (HD) encodes the 348-kDa
huntingtin (HTT) protein. Pathogenic HD CAG-expansion mutations create a polyglutamine (polyQ…
huntingtin (HTT) protein. Pathogenic HD CAG-expansion mutations create a polyglutamine (polyQ…
Adaptive immunity to SARS-CoV-2 in cancer patients: the CAPTURE study
There is a pressing need to characterise the nature, extent and duration of immune response
to SARS-CoV-2 in cancer patients and inform risk-reduction strategies and preserve cancer …
to SARS-CoV-2 in cancer patients and inform risk-reduction strategies and preserve cancer …